PAREXEL Consulting Expands Risk Mgmt Expertise, Appoints Former FDA Consumer Safety Officer Raymond T Oji as Senior Consultant
16th Nov 2006, 08:21 GMT
PAREXEL Consulting has further expanded its risk mgmt and strategic compliance expertise with the appointment of Raymond T Oji to senior consultant.
PAREXEL Consulting Expands Risk Mgmt Expertise, Appoints Former FDA Consumer Safety Officer Raymond T Oji as Senior Consultant related news:
- Drug Safety Reform and Risk Management Plans - A Test Case? Senior FDA Policymakers and Experts to Answer Urgent Questions at Windhover's FDA/CMS Summit Dec 4-5, Washington, DC — RedOrbit News - Health
- European Medicines Agency Appoints Senior Medical Officer — Health News from Medical News Today
- FDA Safety Changes: Prevacid NapraPAC, Epzicom, Forane — Medscape Neurology Headlines
- List of Top Holiday Safety Tips Released — US Consumer Product Safety Commission
- Health Integrated to Speak at World Research Group Summit on Disease Mgmt for Depression — Insurance/ Managed Care News from StratCenter.com
- Atos Consulting appoints new Partner to join Private Sector Team — WebWire - Recent Headlines
- KB Toys, Inc. Appoints Joel R. Wiest Senior Vice President and Chief Financial Officer — PR Newswire: All Releases
- New Corporate Members and Leaders for C-Path's Predictive Safety Testing Consortium Announced — FDA News News from StratCenter.com
- OpenPages: OpenPages and ABS Consulting Team to Provide Comprehensive Operational Risk Management Data Solution — Market Wire - Computers and Software
- FDA Expands Use of Abbott's Humira — Government/ Industry Regulation News from StratCenter.com
Latest news from FDA News News from StratCenter.com:
- North American Gets Cancer Treatment OK
- North American Scientific Announces FDA Clearance of its ClearPath HDR Breast Brachytherapy System
- Newly FDA Approved SmartLipo Laser Liposuction Available at the Intimate Rejuvenation and Innovative Surgery Center, Phoenix, AZ.
- ACT-AD Coalition Calls FDA's New Focus on Neurological Diseases a Positive 1st Step
- Ivax Diagnostics Delays Filing 3Q Report
- New Corporate Members and Leaders for C-Path's Predictive Safety Testing Consortium Announced
- Diagnosoft Receives FDA Approval for Cardiac MRI Quantitative Regional Function Software Based on the HARP Technology
- Trubion Pharmaceuticals to Present at the Lazard Life Sciences Conference
- Critical Therapeutics Announces Efficacy Data for Controlled-Release Formulation of Zileuton Presented at ACAAI 2006 Annual Meeting
- FermaVir's Founder and Board Member Professor Chris McGuigan receives the Royal Society of Chemistry's Award for Medicinal Chemistry